Becton, Dickinson and Co. | BDX - Zahlungsmittel Und Äquivalente





Zahlungsmittel Und Äquivalente Veränderung Datum
Abbott USD 6.8B 1.72B 2026-03
Agilent USD 1.81B 49M 2026-03
Align Technology USD 1.1B 42.76M 2026-06
AngioDynamics USD 41.64M 14.26M 2025-09
Baxter International USD 2.15B 133M 2026-06
Becton, Dickinson and Co. USD 708M 105M 2026-06
Bio-Rad Laboratories USD 517M 9.8M 2026-06
Boston Scientific USD 539M 914M 2026-06
Cooper Companies USD 124.9M 14.3M 2025-12
Danaher USD 4.35B 1.35B 2026-06
Dentsply International USD 239M 49M 2026-06
Dexcom USD 1.1B 13.2M 2026-06
Edwards Lifesciences USD 2.9B 500M 2026-06
Globus Medical USD 507.74M 53.2M 2026-06
Insulet USD 534.9M 54.5M 2026-06
Integra LifeSciences USD 214.42M 22.39M 2026-06
Intuitive Surgical USD 8.63B 646.3M 2026-06
J&J USD 20.42B 1.27B 2026-06
Medtronic USD 1.15B 135M 2025-12
Solventum Corp USD 403M 158M 2026-06
Stryker USD 3.39B 513M 2026-06
Tandem Diabetes Care USD 62.82M 116.51M 2026-06
Teleflex USD 300.16M 9.25M 2026-06
Terumo JPY 280.49B 63.34B 2026-03
Thermo Fisher Scientific USD 3.25B 6.6B 2026-03
Zimmer Biomet Holdings USD 410M 14.2M 2026-06